On the evening of October 27, Shijiazhuang Yiling Pharmaceutical Co., Ltd. (Yiling Pharmaceutical) released its third-quarter report for 2025. The company reported operating revenue of 1,827,460,855.67 yuan, a year-on-year increase of 3.78%. Net profit attributable to shareholders of the listed company reached 331,869,647.18 yuan, surging 1264.61% compared to the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments